Learn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more
UCSF has received approval for plans to build a state-of-the-art hospital at UCSF Helen Diller Medical Center at Parnassus Heights to meet the region’s growing demand for specialty care and California’s rigorous hospital seismic requirements.
Kathy Giacomini, PhD, who trained as a pharmacist and went on to become one of the foremost experts on pharmacogenomics with a focus on drug transporters, has been appointed dean of the UCSF School of Pharmacy.
For the 15th year in a row, UCSF garnered the top spot among public institutions in funding from the National Institutes of Health (NIH) in 2021. UCSF continued to rank highly among all public and private institutions nationwide, ranking fourth overall.
COVID-19 vaccines for our communities. A Nobel Prize. Scientific breakthroughs and advancements in patient care. Innovation in education. While it has been a challenging year, there are many examples of what makes UCSF a special place. Take a moment to reflect on some of the moments from this past year that exemplify what we do.
UCSF has created its first community investment pilot program, with a $5 million investment for four Bay Area financial intermediary partners to provide housing assistance, employment and small business loans to community members and minority-owned local businesses in San Francisco and the East Bay.
After more than four decades at UCSF, B. Joseph Guglielmo, PharmD, dean of the UCSF School of Pharmacy, who has led for nearly 10 years what is widely regarded as the best pharmacy school in the nation, has announced that he will retire December 31, 2021.
UCSF is launching a new initiative to propel the development of living therapeutics – a category of treatments broadly defined as human and microbial living cells that are selected, modified, or engineered to treat or cure disease – and bring them quickly to patients.
The newly named Sandler Program for Breakthrough Biomedical Research – previously known as the Program in Breakthrough Biomedical Research (PBBR) – has for 23 years supported the boldest, least explored research ideas in the life sciences.
UCSF leaders Sam Hawgood, Mark Laret, and Renee Navarro issue a statement to the Bay Area community condemning a recent increase in assaults against the Asian American and Pacific Islander communities.
In 2020, UCSF again was the top public recipient of funding from the National Institutes of Health, maintaining the spot for the 14th year in a row. UCSF continued to rank high among all public and private institutions nationwide, ranking third overall.